💊
Rhucin
recombinant human C1 inhibitor
Angioødem
❌ Refused
✅
Ingen aktive alarmer
Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.
Hvad det bruges til
Replacement treatment in acute attacks of angioedema in patients with congenital C1INH activity deficiency.
⚠️ Patient sikkerhed
No
Officiel EMA-side
https://www.ema.europa.eu/en/medicines/human/EPAR/rhucin